Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0001209191-23-037284

Options or other derivatives

  • Director acquired 18,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Dallas Jayson Donald Alexander Director 2023-06-17 Grant or award · Stock Option (right to buy) +18,000 18,000 D
Loading xslF345X04/doc4.xml…